CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27Kip1 Protein turnover: An independent prognosticator with potential p27Kip1-Independent oncogenic attributes?

Annals of Surgical Oncology

Volumn 17, Issue 3, 2010, Pages 907-922

  Huang, Ching Wen ^a,b   Lin, Ching Yih ^c   Huang, Hsuan Ying ^d   Liu, Hui Wen ^b   Chen, Yi Ju ^d   Shih, Deng Fuh ^a   Chen, Hong Yaw ^a   Juan, Chung Chou ^a   Ker, Chen Guo ^e,f   Huang, Chi Ying F ^g   Li, Chien Feng ^c   Shiue, Yow Ling ^b  

^a YUAN'S GENERAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CKS1B PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; S PHASE KINASE ASSOCIATED PROTEIN 2; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL FEATURE; DISEASE FREE SURVIVAL; FEMALE; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77149153065     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0779-8     Document Type: Article

References (42)

1. X Chen ST Cheung S So, et al. 2002 Gene expression patterns in human liver cancers Mol Biol Cell. 3 1929 1939 10.1091/mbc.02-02-0023. (Pubitemid 34651483)
2. EA Egan MJ Solomon 1998 Cyclin-stimulated binding of Cks proteins to cyclin-dependent kinases Mol Cell Biol. 18 3659 3667 1:CAS:528: DyaK1cXkt1Squrk%3D 9632748
3. D Ganoth G Bornstein TK Ko, et al. 2001 The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27 Nat Cell Biol. 3 321 324 10.1038/35060126 1:CAS:528:DC%2BD3MXitFemtrg%3D 11231585 (Pubitemid 32201330)
4. I Urbanowicz-Kachnowicz N Baghdassarian C Nakache, et al. 1999 ckshs expression is linked to cell proliferation in normal and malignant human lymphoid cells Int J Cancer. 82 98 104 10.1002/(SICI)1097-0215(19990702)82: 1<98::AID-IJC17>3.0.CO;2-A 1:CAS:528:DyaK1MXktVant70%3D 10360827 (Pubitemid 29266113)
5. Y Hu H Sun J Drake, et al. 2004 From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies Cancer Res. 64 7748 7755 10.1158/0008-5472.CAN-04-1827 1:CAS:528:DC%2BD2cXptFemurY%3D 15520179 (Pubitemid 39446906)
6. C Spruck H Strohmaier M Watson, et al. 2001 A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1 Mol Cell. 7 639 650 10.1016/S1097-2765(01)00210-6 1:CAS:528:DC%2BD3MXivVCmtL0%3D 11463388 (Pubitemid 32706355)
7. J Bloom M Pagano 2003 Deregulated degradation of the cdk inhibitor p27 and malignant transformation Semin Cancer Biol. 13 41 47 10.1016/S1044-579X(02) 00098-6 1:CAS:528:DC%2BD38XpvVWksr8%3D 12507555 (Pubitemid 36269179)
8. Y Ito N Matsuura M Sakon, et al. 1999 Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence Hepatology. 30 90 99 10.1002/hep.510300114 1:STN:280: DyaK1MzhsFOnsA%3D%3D 10385644 (Pubitemid 29300574)
9. C Armengol L Boix O Bachs, et al. 2003 p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma J Hepatol. 38 591 597 10.1016/S0168-8278(03)00025-4 1:CAS:528:DC%2BD3sXjtFert7o%3D 12713869 (Pubitemid 36560643)
10. M Fiorentino A Altimari A D'Errico, et al. 2000 Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma Clin Cancer Res. 6 3966 3972 1:CAS:528:DC%2BD3cXotVykurw%3D 11051245
11. D Sun H Ren M Oertel RS Sellers L Zhu 2007 Loss of p27Kip1 enhances tumor progression n chronic hepatocyte injury-induced liver tumorigenesis with widely ranging effects on Cdk2 or Cdc2 activation Carcinogenesis. 28 1859 1866 10.1093/carcin/bgm079 1:CAS:528:DC%2BD2sXhtFWhurnM 17434927 (Pubitemid 47500596)
12. A Tannapfel D Grund A Katalinic, et al. 2000 Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma Int J Cancer. 89 350 355 10.1002/1097-0215(20000720)89:4<350::AID-IJC6>3.0. CO;2-3 1:CAS:528:DC%2BD3cXlvFagsbs%3D 10956409 (Pubitemid 30620288)
13. D Sitry MA Seeliger TK Ko, et al. 2002 Three different binding sites of Cks1 are required for p27-ubiquitin ligation J Biol Chem. 277 42233 42240 10.1074/jbc.M205254200 1:CAS:528:DC%2BD38XotF2gtbk%3D 12140288 (Pubitemid 35257543)
14. V Ouellet MC Guyot C Le Page, et al. 2006 Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer Int J Cancer. 119 599 607 10.1002/ijc.21902 1:CAS:528:DC%2BD28Xmtlyjs7s%3D 16572426 (Pubitemid 43955714)
15. F Zhan S Colla X Wu, et al. 2007 CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms Blood. 109 4995 5001 10.1182/blood-2006-07-038703 1:CAS:528:DC%2BD2sXmt1Onsrg%3D 17303695 (Pubitemid 46827799)
16. G Chiappetta C De Marco A Quintiero, et al. 2007 Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer Endocr Relat Cancer. 14 405 420 10.1677/ERC-06-0030 1:CAS:528:DC%2BD2sXhtV2lsr3J 17639054 (Pubitemid 47242639)
17. DD Hershko M Shapira 2006 Prognostic role of p27Kip1 deregulation in colorectal cancer Cancer. 107 668 675 10.1002/cncr.22073 1:CAS:528: DC%2BD28XpsFGktLo%3D 16826582 (Pubitemid 44232659)
18. K Kawakami H Enokida T Tachiwada K Nishiyama N Seki M Nakagawa 2007 Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma J Urol. 178 301 307 10.1016/j.juro.2007.03.002 1:CAS:528:DC%2BD2sXnvFamur0%3D 17499794 (Pubitemid 46898455)
19. S Kitajima Y Kudo I Ogawa, et al. 2004 Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation Am J Pathol. 165 2147 2155 1:CAS:528:DC%2BD2MXhs1Kmsw%3D%3D 15579456
20. TA Masuda H Inoue K Nishida, et al. 2003 Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma Clin Cancer Res. 9 5693 5698 1:CAS:528:DC%2BD3sXpsVejurc%3D 14654553
21. M Shapira O Ben-Izhak B Bishara, et al. 2004 Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma Cancer. 100 1615 1621 10.1002/cncr.20172 1:CAS:528:DC%2BD2cXjvFygtL4%3D 15073847 (Pubitemid 38456336)
22. M Shapira O Ben-Izhak S Linn B Futerman I Minkov DD Hershko 2005 The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma Cancer. 103 1336 1346 10.1002/cncr.20917 1:CAS:528: DC%2BD2MXjtFamsbs%3D 15717322 (Pubitemid 40410727)
23. M Slotky M Shapira O Ben-Izhak, et al. 2005 The expression of the ubiquitin ligase subunit Cks1 in human breast cancer Breast Cancer Res. 7 R737 R744 10.1186/bcr1278 1:CAS:528:DC%2BD2MXpvFOgtLc%3D 16168119
24. YS Tsai HC Chang LY Chuang WC Hung 2005 RNA silencing of Cks1 induced G2/M arrest and apoptosis in human lung cancer cells IUBMB Life. 57 583 589 10.1080/15216540500215531 1:CAS:528:DC%2BD2MXpvVSgs7k%3D 16118116 (Pubitemid 41344593)
25. DM Takanishi Jr R Severino LL Wong 2007 The Cancer of the Liver Italian Program (CLIP) score: validation of a new prognostic system for hepatocellular carcinoma Hawaii Med J. 66 209 212 17941373
26. Lee CL HK YL Chen YL Shiue 2009 Identification of candidate genes in congenital ventricular septal defects with HSA22q11 loss of heterozygosity Rev Esp Cardiol. 62 263 272 10.1016/S1885-5857(09)71555-5
27. YL Shiue LR Chen CF Chen, et al. 2006 Identification of transcripts related to high egg production in the chicken hypothalamus and pituitary gland Theriogenology. 66 1274 1283 10.1016/j.theriogenology.2006.03.037 1:CAS:528:DC%2BD28Xotleqsbc%3D 16725186 (Pubitemid 44232948)
28. J Gollub CA Ball G Binkley, et al. 2003 The Stanford Microarray Database: data access and quality assessment tools Nucleic Acids Res. 31 94 96 10.1093/nar/gkg078 1:CAS:528:DC%2BD3sXhvFSnsrY%3D 12519956 (Pubitemid 36150342)
29. M Voiculescu RE Winkler M Moscovici MG Neuman 2008 Chemotherapies and targeted therapies in advanced hepatocellular carcinoma: from laboratory to clinic J Gastrointestin Liver Dis. 17 315 322 18836626
30. H Tang XY Tang M Liu X Li 2008 Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle Clin Chim Acta. 394 81 88 10.1016/j.cca.2008.04.012 1:CAS:528:DC%2BD1cXmvFemsL4%3D 18485897
31. VE Gurtsevitch 2008 Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis Biochemistry (Mosc) 73 504 513 10.1134/S0006297908050039 1:CAS:528:DC%2BD1cXmsFKhurw%3D (Pubitemid 351775074)
32. Q Zhou Q He LJ Liang 2003 Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance World J Gastroenterol. 9 2450 2454 1:CAS:528:DC%2BD3sXhtVSjtL7L 14606074
33. HY Huang HY Kang CF Li, et al. 2006 Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas Clin Cancer Res. 12 487 498 10.1158/1078-0432.CCR-05-1497 1:CAS:528: DC%2BD28XmtlKitQ%3D%3D 16428491 (Pubitemid 43166140)
34. N Inui K Kitagawa S Miwa, et al. 2003 High expression of Cks1 in human non-small cell lung carcinomas Biochem Biophys Res Commun. 303 978 984 10.1016/S0006-291X(03)00469-8 1:CAS:528:DC%2BD3sXisFSnsro%3D 12670508 (Pubitemid 36384952)
35. J Vervoorts B Luscher 2008 Post-translational regulation of the tumor suppressor p27(KIP1) Cell Mol Life Sci. 65 3255 3264 10.1007/s00018-008-8296-7 1:CAS:528:DC%2BD1cXht1eqtLrP 18636226
36. KV Bhatt R Hu LS Spofford AE Aplin 2007 Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells Oncogene. 26 1056 1066 10.1038/sj.onc.1209861 1:CAS:528:DC%2BD2sXhslWhtLc%3D 16924241 (Pubitemid 46272211)
37. MA Kouvaraki AL Korapati GZ Rassidakis, et al. 2006 Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma Cancer Res. 66 8581 8589 10.1158/0008-5472.CAN-06-0975 1:CAS:528:DC%2BD28XovF2itLs%3D 16951171 (Pubitemid 44449172)
38. L Westbrook M Manuvakhova FG Kern NR Estes II HN Ramanathan JV Thottassery 2007 Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells Cancer Res. 67 11393 11401 10.1158/0008-5472.CAN- 06-4173 1:CAS:528:DC%2BD2sXhtlyiu73F 18056467 (Pubitemid 350248567)
39. R Hu AE Aplin 2008 Skp2 regulates G2/M progression in a p53-dependent manner Mol Biol Cell. 19 4602 4610 10.1091/mbc.E07-11-1137 1:CAS:528: DC%2BD1cXhtlKqsbbN 18716061
40. DF Calvisi F Pinna F Meloni, et al. 2008 Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma Cancer Res. 68 4192 4200 10.1158/0008-5472.CAN-07-6157 1:CAS:528:DC%2BD1cXmsFKmtb8%3D 18519678
41. IC Wang YJ Chen D Hughes, et al. 2005 Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase Mol Cell Biol. 25 10875 10894 10.1128/MCB.25.24.10875-10894.2005 1:CAS:528:DC%2BD2MXhtlektr%2FO 16314512 (Pubitemid 41747132)
42. W Wang D Ungermannova L Chen X Liu 2004 Molecular and biochemical characterization of the Skp2-Cks1 binding interface J Biol Chem. 279 51362 51369 10.1074/jbc.M405944200 1:CAS:528:DC%2BD2cXhtVaqs77E 15452136 (Pubitemid 40017883)